Now Reading
Could It Be True? New Drug Promises To Prevent HIV

Could It Be True? New Drug Promises To Prevent HIV

SAN ANSELMO, CA - NOVEMBER 23: Bottles of antiretroviral drug Truvada are displayed at Jack's Pharmacy on November 23, 2010 in San Anselmo, California. A study published by the New England Journal of Medicine showed that men who took the daily antiretroviral pill Truvada significantly reduced their risk of contracting HIV. (Photo Illustration by Justin Sullivan/Getty Images)
(Photo Illustration by Justin Sullivan/Getty Images)

According to research data, up to two million new HIV infections still, occur yearly worldwide. Recent studies have shown that pre-exposure prophylaxis with antiretroviral medications is a potential way to prevent new infections among those at risk. Your health is important!

A few days ago, an openly gay Nigerian man, Kenny Badmus who relocated to the US in January 2015 after coming out of the closet revealed (on his Facebook page) just how much he misses Nigeria and how saddened he is over not being able to go back home for fear of being killed over his sexuality. He also expressed that although he’s homesick and quite lonely, he is happy he lives in a country where he can walk the streets as a gay man without feeling endangered. He also revealed that he’s HIV positive.

There are millions of homosexual and heterosexual persons living with HIV all over the world.  But it seems hope is on the horizon as a new drug is known as PrEP (Tenofovir-emtricitabine) promises HIV prevention in the at-risk population.

PrEP trials in various populations, including men who have sex with men, heterosexual individuals with an HIV-infected partner, heterosexual people in areas of high HIV prevalence, and injection drug users, have demonstrated a reduction in the risk of HIV infection by 44 to 90 per cent with daily use of tenofovir-emtricitabine compared with placebo. The level of protection was greater among participants who were highly adherent to medication (measured by drug levels). Most patients in these trials also received risk reduction counselling which encouraged condom use, as well as screening and treatment for sexually transmitted diseases.

For more information about PrEP, visit NIH – Aids Info

Summarized by Reagan A. (US-licensed healthcare provider – Psychiatric NP)

Culled from

Photo credit: The Washington Post

Leave Comment

Leave a Reply

Scroll To Top